444 related articles for article (PubMed ID: 7005387)
1. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.
Gastel B; Cornoni-Huntley J; Brody JA
J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387
[TBL] [Abstract][Full Text] [Related]
2. Estrogen use and postmenopausal women.
United States. National Institute on Aging
NIH Consens Dev Conf Summ; 1979; 2(8):1-5. PubMed ID: 12336054
[TBL] [Abstract][Full Text] [Related]
3. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
Stefanick ML
Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
[TBL] [Abstract][Full Text] [Related]
4. Estrogen prescribing practices scrutinized at NIH conference.
Eichelberger BM
Am J Hosp Pharm; 1979 Dec; 36(12):1728. PubMed ID: 525651
[TBL] [Abstract][Full Text] [Related]
5. Clinical use of progestins in the menopausal patient: dosage and duration.
Gambrell RD
J Reprod Med; 1982 Aug; 27(8 Suppl):531-8. PubMed ID: 7131446
[TBL] [Abstract][Full Text] [Related]
6. National Institutes of Health Consensus Development Conference Statement: breast cancer screening for women ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Developmental Panel.
J Natl Cancer Inst Monogr; 1997; (22):vii-xviii. PubMed ID: 9709265
[TBL] [Abstract][Full Text] [Related]
7. Exogenous estrogens and endometrial carcinoma: review and comments for the clinician.
Berger GS; Fowler WC
J Reprod Med; 1977 Apr; 18(4):177-80. PubMed ID: 870690
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
9. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
10. Estrogen replacement therapy.
Judd HL; Cleary RE; Creasman WT; Figge DC; Kase N; Rosenwaks Z; Tagatz GE
Obstet Gynecol; 1981 Sep; 58(3):267-75. PubMed ID: 7022279
[TBL] [Abstract][Full Text] [Related]
11. Postmenopausal hormone therapy: from monkey glands to transdermal patches.
Davis SR; Dinatale I; Rivera-Woll L; Davison S
J Endocrinol; 2005 May; 185(2):207-22. PubMed ID: 15845914
[TBL] [Abstract][Full Text] [Related]
12. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
Gambrell RD
Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
14. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
15. The menopause.
Brenner PF
West J Med; 1982 Mar; 136(3):211-9. PubMed ID: 7090370
[TBL] [Abstract][Full Text] [Related]
16. Consensus Development Summaries. Estrogen use and postmenopausal women. Sponsored by the National Institute on Aging, assisted by the Office for Medical Applications of Research, NIH.
Conn Med; 1980 Feb; 44(2):85, 87-8. PubMed ID: 7363614
[No Abstract] [Full Text] [Related]
17. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
18. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
[TBL] [Abstract][Full Text] [Related]
19. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
Levine JP
Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
[TBL] [Abstract][Full Text] [Related]
20. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
Josse RG
CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
